On February 27, 2012, the Alliance for Safe Biologic Medicines and Bloomberg Government hosted a lunch time Biosimilars Forum on Capitol Hill to discuss the FDA’s draft guidance documents on biosimilar product development.

Panelists included:

• Brian Rye, Health-Care Financial Analyst with Bloomberg Government (moderator)
• Dr. Richard Dolinar, Chairman of the Alliance for Safe Biologic Medicines
• Dr. David Charles, Chief Medical Officer, Vanderbilt Neuroscience Institute, Chairman of the Alliance for Patient Access, and ASBM member partner
• Seth Ginsberg, Co-Founder and President of the Global Health Living Foundation, and ASBM member partner
• Andrew Spiegel, CEO and co-founder of the Colon Cancer Alliance, and ASBM member partner
• Martha Raymond, Patient Advocate, Colon Cancer Alliance
• Jeffrey P. Kushan, Partner, Sidley-Austin LL

 

For audio of the event see below:

• Brian Rye
  1. Introduction of Ginsberg, Spiegel, & Raymond Audio
  2. Introduction of Richard Dolinar, & David Charles Audio
• Dr. Richard Dolinar Audio
• Dr. David Charles Audio
• Seth Ginsberg Audio
• Andrew Speigel Audio
• Martha Raymond Audio
• Jeffrey P. Kushan Audio